vs
Immunovant, Inc.（IMVT）与JOINT Corp（JYNT）财务数据对比。点击上方公司名可切换其他公司
JOINT Corp的季度营收约是Immunovant, Inc.的1.8倍（$15.2M vs $8.4M），JOINT Corp净利率更高（6.5% vs -899.0%，领先905.5%），Immunovant, Inc.同比增速更快（140.7% vs 3.1%），JOINT Corp自由现金流更多（$334.7K vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
JOINT Corp是美国领先的脊椎按摩护理诊所运营方与特许经营商，主打高性价比的脊椎护理服务，推出会员制护理方案，面向寻求非侵入式肌肉骨骼疼痛管理及日常健康调理的消费者。
IMVT vs JYNT — 直观对比
营收规模更大
JYNT
是对方的1.8倍
$8.4M
营收增速更快
IMVT
高出137.7%
3.1%
净利率更高
JYNT
高出905.5%
-899.0%
自由现金流更多
JYNT
多$60.2M
$-59.8M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $15.2M |
| 净利润 | $-75.3M | $991.1K |
| 毛利率 | — | 81.4% |
| 营业利润率 | -896.2% | 4.9% |
| 净利率 | -899.0% | 6.5% |
| 营收同比 | 140.7% | 3.1% |
| 净利润同比 | -26.7% | 5510.5% |
| 每股收益（稀释后） | $-0.50 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTJYNT
| Q4 25 | — | $15.2M | ||
| Q3 25 | — | $13.4M | ||
| Q2 25 | — | $13.3M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | — | $30.2M | ||
| Q2 24 | — | $30.3M | ||
| Q1 24 | $8.4M | $29.7M |
净利润IMVTJYNT
| Q4 25 | — | $991.1K | ||
| Q3 25 | — | $855.0K | ||
| Q2 25 | — | $93.4K | ||
| Q1 25 | — | $967.8K | ||
| Q4 24 | — | $17.7K | ||
| Q3 24 | — | $-3.2M | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | $-75.3M | $947.0K |
毛利率IMVTJYNT
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 80.1% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 90.7% | ||
| Q2 24 | — | 90.7% | ||
| Q1 24 | — | 90.9% |
营业利润率IMVTJYNT
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -5.2% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | -896.2% | -1.4% |
净利率IMVTJYNT
| Q4 25 | — | 6.5% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | -10.5% | ||
| Q2 24 | — | -11.9% | ||
| Q1 24 | -899.0% | 3.2% |
每股收益（稀释后）IMVTJYNT
| Q4 25 | — | $0.06 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $-0.21 | ||
| Q2 24 | — | $-0.24 | ||
| Q1 24 | $-0.50 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $23.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $15.1M |
| 总资产 | $666.4M | $61.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTJYNT
| Q4 25 | — | $23.6M | ||
| Q3 25 | — | $29.7M | ||
| Q2 25 | — | $29.8M | ||
| Q1 25 | — | $21.9M | ||
| Q4 24 | — | $25.1M | ||
| Q3 24 | — | $20.7M | ||
| Q2 24 | — | $17.5M | ||
| Q1 24 | $635.4M | $18.7M |
股东权益IMVTJYNT
| Q4 25 | — | $15.1M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | — | $22.8M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $23.2M | ||
| Q1 24 | $617.8M | $26.2M |
总资产IMVTJYNT
| Q4 25 | — | $61.0M | ||
| Q3 25 | — | $69.4M | ||
| Q2 25 | — | $73.2M | ||
| Q1 25 | — | $80.1M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $79.6M | ||
| Q2 24 | — | $82.4M | ||
| Q1 24 | $666.4M | $85.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $334.7K |
| 自由现金流率自由现金流/营收 | -714.4% | 2.2% |
| 资本支出强度资本支出/营收 | 1.8% | 9.9% |
| 现金转化率经营现金流/净利润 | — | 1.86× |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $-1.9M |
8季度趋势，按日历期对齐
经营现金流IMVTJYNT
| Q4 25 | — | $1.8M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $868.6K | ||
| Q1 25 | — | $-3.7M | ||
| Q4 24 | — | $9.4M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $-973.5K | ||
| Q1 24 | $-59.7M | $2.8M |
自由现金流IMVTJYNT
| Q4 25 | — | $334.7K | ||
| Q3 25 | — | $1.5M | ||
| Q2 25 | — | $363.6K | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $8.2M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | $-59.8M | $2.4M |
自由现金流率IMVTJYNT
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 10.9% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | -30.8% | ||
| Q4 24 | — | 55.9% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | — | -4.1% | ||
| Q1 24 | -714.4% | 8.1% |
资本支出强度IMVTJYNT
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | 1.8% | 1.3% |
现金转化率IMVTJYNT
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMVT
暂无分部数据
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
